The race between Amy Acton and Vivek Ramaswamy could be the election’s most direct test of where the heartland stands on health care and the pandemic.

The rushed launch of a Medicare pilot to use AI for prior authorization led to delayed care in some instances, new documents reveal.

A U.K. commission has unveiled its recommendations for how the country should regulate artificial intelligence in medicine.

A newly approved AI tool can scan EKGs for severe heart attacks and, the company says, for rarer patterns indicating blocked arteries.

ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial intelligence bots that direct treatment of heart failure.

Rural health care providers have struggled for years. The Trump administration is pointing to a cutting-edge, if unproven way to save them: artificial intelligence.

Brittany Trang's subscriber-exclusive weekly newsletter unpacks the intersection of AI, health, and medicine.

Scientists have made mice with half a brain, then filled them with human organoids — possibly opening new avenues for research but also raising ethical issues.

The rushed launch of a Medicare pilot to use AI for prior authorization led to delayed care in some instances, new documents reveal.

Marc Tessier-Lavigne released new details from his research and travel in an attempt to refute allegations in a new book that he published fraudulent results.

Epic Systems is the subject of a broad inquiry into its business practices, people who were contacted by FTC investigators told STAT.

Commure wants to automate health care's administrative tasks with AI. An inside look at the messy realities of the startup's ambitious quest.

Commure, which develops and sells AI products to clinics, has terminated a program that paid for referrals to new customers.

Commure wants to automate health care's administrative tasks with AI. An inside look at the messy realities of the startup's ambitious quest.

President Trump has said the MMR vaccine should be broken up. But experts see no medical benefit in separating one shot into three.

Now confirmed, Erica Schwartz is the third CDC nominee since Trump took office his second term.

Parents want accountability after study went disastrously wrong, Science and Retraction Watch investigation reveals

In this edition of AI Prognosis, Brittany Trang talks to Alex LeBrun, AI scribe company Nabla's executive chairman, about an alternative to LLMs

The U.S. can save lives from excess alcohol use without taking drastic measures. Here are 12 steps that can help.

Take this survey powered by surveymonkey.com. Create your own surveys for free.

Join the STAT+ community today and enjoy unlimited access to award-winning journalism, premium data tools, discounted event tickets, and much more.

“AI will reshape medicine. The physicians who answer for the outcome must lead the way it enters patient care," write Afnan R. Tariq and Ami Bhatt.

Create an account or log in to Instagram - Share what you're into with the people who get you.

An expert on environmental policy measured every drop of water he used during months of heavy AI work. The findings reveal we may be worrying about the wrong environmental crisis.

Columbus data centers used 1.2 billion gallons of water in a 12-month period, which amounts to 3% of Columbus' water in that time.

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, those doing research at pharma companies.

AI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.

Bonus material: You might think yesterday, with the Claude Science and drug development announcements, was the moment I thought Anthropic was serious about science. But that moment actually happened a...

AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of artificial intelligence. Can it make drugs too?

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, those doing research at pharma companies.

Biotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.

I'm here at #BIO2026 and have some early takeaways on what's poppin' and what's next for AI in biotech. Drop any trends you're seeing below! 👇 and subscribe to AI Prognosis, which drops Wednesday at 7...

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.

Health disparities researchers say a new White House proposal could disqualify much of their work from federal funding — perhaps the most serious threat yet to the future of their field.

The psychiatric ER is “a detox center for those with no safe place to withdraw and a respite center for caregivers at their breaking point,” writes a psychiatrist.

As the saying goes, one man’s trash is another man’s treasure. Or as Verge Labs might put it, one company’s failed clinical trial … is that same company’s

STAT introduces a goals and promises tracker for Robert F. Kennedy Jr.'s Make America Healthy Again movement — successes, incompletes, and fails.

None of STAT's requests for Kennedy's schedule have been completed, and some haven't even been acknowledged.